PALM BEACH, Fla. – The first day of the National Association of Chain Drug Stores Annual Meeting got off to a fast start at a breakfast on GLP-1s sponsored by retailmediaIQ, publisher of Chain Drug Review and MMR. Building on a webinar devoted to the same topic earlier this year, the session addressed the latest developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors. Moderated by Parag Shah, co-founder, partner and chief growth officer at Think Blue, the panelists included Jim Kirby, chief commercial officer at Kroger Health, Betty Pio, a partner and strategic advisor to pharma and biotech at Kearney, and Sarah Squires, director of Retail Insights Drug Channel at NielsenIQ.
CDR/MMR breakfast at NACDS Annual looks at the latest developments in GLP-1 category
The session addressed the latest GLP-1 developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors.
Latest
VAB releases The Pharmacy, a comprehensive guide answering key questions in the pharma DTC category
Culmination of 18 months of industry bonversations delivers updated data and new insights on the pharma sdvertising landscape
KNAPP establishes robotics and AI innovation hub in Boston
The new business boosts the development of AI-powered robotics solutions for warehouse automation and intelligent fulfillment processes.
Ampelis introduces CORE7 nutrition drink mix for children
CORE7 for Kids was developed with individual ingredient amounts evaluated for growing children.
CRN challenges study linking caffeine to heart risks
The Council for Responsible Nutrition says a preliminary caffeine study cannot establish causation or quantify cardiovascular risks for consumers.